Welcome to LookChem.com Sign In|Join Free
  • or
4-chloro-2-(2-methoxy-phenyl)-quinoline is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

178990-29-9

Post Buying Request

178990-29-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

178990-29-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 178990-29-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,8,9,9 and 0 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 178990-29:
(8*1)+(7*7)+(6*8)+(5*9)+(4*9)+(3*0)+(2*2)+(1*9)=199
199 % 10 = 9
So 178990-29-9 is a valid CAS Registry Number.

178990-29-9Relevant academic research and scientific papers

4-aminoquinoline compound, and preparation method and application thereof

-

Paragraph 0032; 0043-0046, (2019/11/12)

The invention discloses a 4-aminoquinoline compound, and a preparation method and application thereof. The second site of the 4-aminoquinoline compound is replaced by cyclic R-base, the 4-aminoquinoline compound is obtained by 4-step reaction of anthranil

AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE

-

Page/Page column 136; 138, (2009/10/06)

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain amino-ethyl-amino-aryl (AEAA) compounds which, inter alia, inhibit protein kinase D (PKD) (e.g., PKD1, PKD2, PKD3). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit PKD, and in the treatment of diseases and conditions that are mediated by PKD, that are ameliorated by the inhibition of PKD, etc., including proliferative conditions such as cancer, etc.

Oxadiazoles as bioisosteric transformations of carboxylic functionalities. II

Andersen,Lundt,Jorgensen,Braestrup

, p. 417 - 425 (2007/10/03)

In order to improve the in vivo efficacy of a series of known benzodiazepine receptor (BZR) ligands, 1-(2-phenyl-4-quinolinyl)-4-piperidinecarboxamides, a series of analogs has been prepared in which the amide group of these ligands has been replaced by a 1,2,4-oxadiazole moiety or converted to other carboxylic isosters such as esters or nitriles. An increase in the in vivo efficacy was observed for some of the compounds prepared in this investigation compared to the parent carboxamide derivatives.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 178990-29-9